EN
HI
Summary
As of 26 Oct, 2026, Concord Drugs stock price is ₹65.02. During the trading session, the stock has moved between an intraday low of ₹65.02 and an intraday high of ₹74.50. Over the last 52 weeks, Concord Drugs has traded between ₹63.00 and ₹92.52.
The stock has recorded a trading volume of 3,528 shares,. Its Average Traded Price (ATP) is ₹66.27, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 50 @ ₹65.02.
Concord Drugs has an upper circuit limit of ₹81.67 and a lower circuit limit of ₹54.45. The total value traded stands at ₹2.34 L, and the delivery percentage for the day is 71.93%.
The stock is currently traded with a market lot size of 1. Concord Drugs also offers a dividend yield of 0%.
Concord Drugs Share Price Chart
Concord Drugs Share Key Metrics
Volume
3528.00
Market Cap
85.73 CR
LTQ@LTP
50@65.02
ATP
66.27
Var Margin
25 %
Circuit Range
54.45-81.67
Delivery %
71.93 %
Value
2.34 L
ASM/GSM
No
Market Lot
1
Concord Drugs Fundamentals
P/E Ratio
43.72
P/B Ratio
1.81
Div. Yield
0
Sector P/E
37.75
Sector P/B
3.1
Sec. Div. Yield
0.54
Concord Drugs Resistance and Support
Pivot 67.69
Resistance
First Resistance
70.38
Second Resistance
72.69
Third Resistance
75.38
Support
First Support
65.38
Second Support
62.69
Third Support
60.38
Concord Drugs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Oct 26 2026 | 74.5 | 65.02 | -4.45% | 74.5 | 65.02 |
| Fri Oct 23 2026 | 67.62 | 68.05 | -1.38% | 70 | 65 |
| Thu Oct 22 2026 | 68 | 69 | 3.36% | 69 | 65 |
Concord Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-27 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-07-03 | Preferential issue of shares |
| 2025-06-27 | Preferential Issue of shares & Others |
| 2025-05-23 | Audited Results |
| 2025-03-17 | Preferential Issue of shares & Others |
| 2025-03-13 | Preferential Issue of shares & Others |
| 2025-01-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Concord Drugs News
Concord Drugs Ltd - 538965 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Concord Drugs Limited has submitted the Scrutinizer's Report and Voting Results for the 31st AGM held on 30.09.2026. All resolutions were approved.
Oct 01 2026 13:36:44
Concord Drugs Management
| Name | Position |
|---|---|
| S Nagi Reddy | Chairman & Managing Director |
| S Koni Reddy | Whole Time Director & Chief Financial Officer |
Concord Drugs FAQs
The Buying Price of Concord Drugs share is 65.02 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Concord Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Concord Drugs shares is 43.72. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Concord Drugs shares is 1.81. Useful to assess the stock's value relative to its book value.
To assess Concord Drugs’s valuation compare Sector P/E, P/B which are 37.75 & 3.1 with sector averages, along with growth rates and financial metrics.
The Market Cap of Concord Drugs is 85.73 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Concord Drugs share price is 92.52 & 63.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Concord Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in CONCORD
